Marker Therapeutics, Inc.
MRKR· Nasdaq
MRKRMarker Therapeutics, Inc.
Filed Mar 23, 2018 · 10-K · 82 days after period end · 0001144204-18-016734
derived · Computed from the longer spans the company filed.
| Metric | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$2.68M | -$1.58M | -$1.65M | -$361.51K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marker Therapeutics, Inc. · CIK 1094038 · Engraved from SEC EDGAR
ended Dec 31, 2017 · filed Mar 23, 2018 · 82 d after period end
